Category Archives: Spinal Cord Injury Treatment

Both Acorda Therapeutics Inc. (NASDAQ:ACOR) and Eiger BioPharmaceuticals Inc. (NASDAQ:EIGR) are each others competitor in the Biotechnology industry. Continue reading →

A spinal stroke has left the triple Olympic gold medallist Pete Reed paralysed from the chest down. Continue reading →

The Spinal Implants and Surgical Devices Market research report 2019-2024 focuses on the major drivers, restraints, opportunities and threats for key players. It also provides granular analysis of market share, segmentation, revenue forecasts and regional analysis till 2024. The report has opinions from industry experts and offers an overview of the past years and the current market situation Continue reading →

The Spinal Implants and Surgical Devices Market research report 2019 has been estimated considering the application and regional segments, market share, and size, while the forecast for each product type and application segment has been provided for the global and regional markets. Spinal Implants and Surgical Devices report offers detailed profiles of the key players to bring out a clear view of the competitive landscape of the Spinal Implants and Surgical Devices outlook Continue reading →

The SMART INSULIN PENS market research report added by Report Ocean, is an in-depth analysis of the latest trends, market size, status, upcoming technologies, industry drivers, challenges, regulatory policies, with key company profiles and strategies of players. The research study provides market introduction, SMART INSULIN PENS market definition, regional market scope, sales and revenue by region, manufacturing cost analysis, Industrial Chain, market effect factors analysis, SMART INSULIN PENS market size forecast, 100+ market data, Tables, Pie Chart, Graphs and Figures, and many more for business intelligence. The global smart insulin pens market was valued at $57 million in 2016, and is estimated to reach $117 million by 2023, growing at a CAGR of 10.7% from 2017 to 2023. Continue reading →

Spinal cord damage that causes paralysis and reduced mobility doesnt always stop with the initial trauma, but there are few treatment options to halt increased deterioration and there is no cure. Researchers at Rensselaer Polytechnic Institute have developed a promising new biomaterial that could offer targeted treatment to the damaged spinal cord and tissue, preventing further damage. In research published today (October 23, 2019) in Nature Communications, an interdisciplinary team from Rensselaer demonstrated how estrogen a natural hormone produced in the body can be polymerized into a slow-releasing biomaterial and applied to nervous system cells to protect those cells and even promote regeneration. Continue reading →

Richard Toselli, M.D., President and Chief Executive Officer of InVivo, said, We made a dedicated effort to efficiently activate strategic clinical sites during the first half of the year and are pleased with the resulting pace of enrollment to date, with our team maintaining focus on enrollment efforts and engagement at the site level. In addition, we appreciate the investigators support of this trial, which we believe has the potential to address a long unmet medical need for spinal cord injury patients. About the INSPIRE 2.0 Study The INSPIRE 2.0 Study is a two-arm 20-patient (10 subjects in each study arm), randomized, controlled trial designed to provide clinical data that will supplement the existing clinical results from the companys previous single-arm study (INSPIRE 1.0) Continue reading →

A research trial funded by insurer and care provider icare has shown improvements in emotional being for those who have a spinal cord injury. Read more: icare Foundation funds program for people with spinal cord injury The research trial explored the effect of an internet-delivered pain course on the emotional wellbeing of 69 people with a spinal cord injury, resulting in 30% to 40% improvements in anxiety and depression and 20% to 30% improvements in disability Continue reading →

Nine widely-used medications have experienced substantial price surges over the past 2 years, adding $5.1 billion to overall drug spending during this time period, according to a new report. Furthermore, 7 of these 9 drugs were found by the Institute of Clinical and Economic Review (ICER) to be lacking sufficient clinical evidence to support such price increases. Not only did adalimumab top the list of best-selling drugs last year, but the anti-inflammatory medication ranked first in terms of the most substantial price hikes from 2016 to 2018 Continue reading →

Bhubaneswar: The advanced treatment of using stem cells for treating Autism and other neurological ailments have come as a ray of hope for the people living with some of these ailments. Medical experts working in the sector claim that the use of the technology improved the lives of many. According to experts who practice stem cell therapy, the results have been overwhelming. Continue reading →